Quotes NAV News Video
UTVi Logo
 Saturday, Jul 04, 2009 Updated 08:33 IST
You are a guest user Register | Sign In
Industry » Pharma & Biotech RSS Feed
Get latest headlines on your desktop
You are here: UTVi» Industry » Pharma & Biotech

Amrutanjan plans foray in Europe, US

PTI
Published on Thu, Nov 20, 2008 at 17:32 IST
Tags: Amrutanjan 
Comment
   
Email Article Print Article Share    
 
 Recent Stories
Maharashtra to build mega power projects
Piaggio to make two wheelers in India
Dollar role in Indian forex may change
AI staff warned of 'harsh' decisions
  More  
 Recent Videos
Budget push for markets
RNRL to file petition in SC
'India wants tax reforms'
What India wants
  More  

CHENNAI: Pharma firm Amrutanjan today said it is planning to enter the European and the US markets shortly and is also embarking on a massive nation-wide campaign to strengthen its leadership position in the country.
    
"We are planning to tap the European and US markets and are working on it," Company's Managing Director Sambhu Prasad said.
    
Besides, it is launching a nation-wide five month campaign -- 'Be Ready' to strengthen its position. "The company would adopt 360 degree approach for marketing and distribution. We are positive about sustaining our leadership position," company's Head-Sales K N Srikanta told reporters here.
    
"The five month campaign, starting November 17, will be carried through various media, including TV, radio, web and through point of sales in malls and also in rural areas. The company proposes to spend around Rs six crore for this," he said.
   
It owns 65% of the market share, with Tamil Nadu contributing 35% followed by Andhra Pradesh of 24%.
    
Last year, it had sold 10.2 lakh units of the yellow-balm range of products and hoped to increase it to 12.5 lakh, Prasad said.
   
The Indian pain balm market was about Rs 600 crore, Prasad said, adding that the company hoped to grow seven to eight per cent year-on-year basis.
    
The company has already been exporting its products to the Gulf countries and to the African markets.
   
"On an average Rs two crore worth of business is done on the exports segment," he said.

 
Rate this article
Comment Email Article Print Article Share      
 
Latest News from Pharma & Biotech
Pharma: India loses, China gains
Sun Pharma to revise guidance
USFDA seizes drugs of Sun Pharma arm
Emami to demerge realty biz
Wockhardt sells German biz to Mova
0 Comments
Post Your Comment
Comment :
Name :
City :
Email :
Verification : Type the text in the picture below
   
   
 

Most Popular News

 
Business Quotient Quiz  
How well do you know your business? Take this quiz and put your gyaan to test
Investor Quotient Quiz  
Like the thrill of risk or prefer the contentment of guarantee? Take the test to know your investor type
Millionaire Dreams  
Want to become a millionaire? Calculate how much you need to set aside each year to save a million rupees
Poll
Do you agree with the PM that rail travel will get more enjoyable?
Yes
No
 
Stock Name: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Fund Name: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
News | Travel | Financial | Income Tax | Fashion | BSE | NSE | Mutual Fund | Stock Market | Sensex | Business News | Futures & Options | commodity | Financial news | share tips
  UTV Network Sites: Bindass | Bindass Movies | UTV Movies | World Movies | UTV Motion Pictures | UTV Spotboy | UTV Television | UTV Toons | Indiagames | Digi-guys
Copyright 2009 UTV New Media Ltd. All rights reserved
About UTVi   |   Site Map  |  Terms of Service  |   Disclaimer  |   Privacy Policy  |   Website Feedback  |   Complaint Redressal  |  Contact Us  |   RSS  |   TechTree